Crown gall is a bacterial disease that has been found to seriously harm susceptible woody plants causing  great financial loss in commercial nurseries where up to 80% of stock have been reported to be diseased.

                         Copyright © New BioProducts, Inc.. All rights reserved.

New BioProducts, Inc.
New BioProducts, Inc.

NBI has no current NOGALL inventory & has ceased operations

New BioProducts, Inc. (NBI) was established in 1985 by Dr. Larry W. Moore who was a professor of Plant Pathology at Oregon State University.  Dr. Moore's crown gall research led to the refinement and commercial production of Norbac 84C, a treatment to prevent crown gall disease based on Agrobacterium radiobacter strain K84.  For decades NBI was dedicated to helping the nursery industry understand crown gall disease, to raise awareness of the latest control methods, and to facilitate the prevention of crown gall.   Once the EPA registration was approved, NBI introduced NOGALL to the USA as the exclusive importer of NOGALL, which was manufactured in Australia. 

After Dr. Moore's tragic accident and death in August 2000, Mike Moore continued to operate the family business.  NOGALL's acceptance, efficacy, market share and sales grew rapidly.   Many growers, nurserymen and orchardists came to rely on NOGALL as the preferred treatment for crown gall prevention.  Years later, January 1, 2013, BASF acquired the production rights to NOGALL.  Supply chain, production planning, inventory management, customs and acquisition became very challenging for NBI.   On June 30, 2015 NBI received a letter from BASF announcing its decision to no longer import NOGALL to the US.  NOGALL was NBI's only product line.  NBI had little choice, but to cease operations.     

It has been a pleasure to serve & work with you .  Thank you for your friendship, understanding & business!

BASF has discontinued NOGALL distribution in the US

Please direct any questions to BASF: Steve (515) 450-7340 or Jennifer (919) 547-2626